Showing results (41-50 of 70) with videos related to
Sort By:
Pageof 7
The Primary Care Companion for CNS Disorders|August 28, 2025
Depression Remission and Response Rates and Anxiety Response as a Predictor of Depression Response in a Community Electroconvulsive Therapy ClinicSara B VanBronkhorst, Joseph J Keller, Evonne M Edwards, et al.Drug and Alcohol Dependence|July 23, 2023
Comparing presumptive with direct-to-definitive drug testing in oral fluid vs. urine for a U.S. national sample of individuals misusing drugsStephen Magura, Miranda J Lee-Easton, Ruqayyah Abu-Obaid, et al.Journal of Affective Disorders|January 18, 2019
An inflammatory profile linked to increased suicide riskSarah A Keaton, Zachary B Madaj, Patrick Heilman, et al.JAMA|January 9, 2014
Maintenance treatment with varenicline for smoking cessation in patients with schizophrenia and bipolar disorder: a randomized clinical trialA Eden Evins, Corinne Cather, Sarah A Pratt, et al.Schizophrenia Bulletin|January 20, 2024
Abnormal Oculomotor Corollary Discharge Signaling as a Trans-diagnostic Mechanism of PsychosisBeier Yao, Martin Rolfs, Rachael Slate, et al.Journal of Clinical Psychopharmacology|June 19, 2013
High-dose oral ziprasidone versus conventional dosing in schizophrenia patients with residual symptoms: the ZEBRAS studyDonald C Goff, Joseph P McEvoy, Leslie Citrome, et al.Translational Psychiatry|January 26, 2022
Cytokines and tryptophan metabolites can predict depressive symptoms in pregnancyQiong Sha, Zach Madaj, Sarah Keaton, et al.Journal of Substance Use|September 24, 2025
Polysubstance use patterns among individuals applying for opioid use disorder treatment in the U.SMiranda Lee-Easton, Stephen Magura, Ruqayyah Abu-Obaid, et al.Journal of Affective Disorders|May 17, 2025
Utilizing depression symptom-based phenotypes to explore ketamine treatment response in major depression: The Bio-K multicenter trialBrandan K Penaluna, Jennifer L Vande Voort, William V Bobo, et al.Neuropsychiatric Disease and Treatment|September 29, 2025
Treatment Patterns and Outcomes from OASIS: A Prospective Observational Study of Long-Acting Injectables in SchizophreniaPeter J Weiden, Lauren N Strand, Michael J Doane, et al.Pageof 7